Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Nature Reviews. Endocrinology
|
December 6, 2023
Type 1 diabetes mellitus: a brave new world
Pieter-Jan Martens, Chantal Mathieu
Nature Reviews. Endocrinology
|
August 18, 2021
One hundred years of insulin therapy
Chantal Mathieu, Pieter-Jan Martens, Roman Vangoitsenhoven
The Journal of Endocrinology
|
March 17, 2021
100 YEARS OF INSULIN: Arresting or curing type 1 diabetes: an elusive goal, but closing the gap
Pieter-Jan Martens, Conny Gysemans, Chantal Mathieu
Nutrients
|
May 2, 2020
Vitamin D's Effect on Immune Function
Pieter-Jan Martens, Conny Gysemans, Annemieke Verstuyf, et al.
Annals of Internal Medicine
|
March 24, 2020
Graves Disease With Thyroid-Stimulating Hormone Receptor-Blocking Autoantibodies During Pregnancy
Brigitte Decallonne, Pieter-Jan Martens, Annick Van den Bruel, et al.
Frontiers in Endocrinology
|
November 29, 2023
Footprint of pancreas infiltrating and circulating immune cells throughout type 1 diabetes development
Ylke Bruggeman, Pieter-Jan Martens, Gabriele Sassi, et al.
Frontiers in Endocrinology
|
November 7, 2022
Preventing type 1 diabetes in late-stage pre-diabetic NOD mice with insulin: A central role for alum as adjuvant
Pieter-Jan Martens, Darcy Ellis, Ylke Bruggeman, et al.
Diabetologia
|
July 12, 2025
Verapamil and low-dose anti-mouse thymocyte globulin combination therapy stably reverses recent-onset type 1 diabetes in NOD mice by acting on the beta cell and immune axes
Laure Degroote, Pieter-Jan Martens, Marijke Viaene, et al.
Frontiers in Immunology
|
July 5, 2022
High Serum Vitamin D Concentrations, Induced <i>via</i> Diet, Trigger Immune and Intestinal Microbiota Alterations Leading to Type 1 Diabetes Protection in NOD Mice
Pieter-Jan Martens, Javier Centelles-Lodeiro, Darcy Ellis, et al.
Frontiers in Endocrinology
|
June 1, 2026
Case Report: Twenty years of metreleptin therapy in congenital generalized lipodystrophy type 1: the longest reported follow-up to date
Elise Van der Borght, Bart Van der Schueren, Roman Vangoitsenhoven, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Nature Reviews. Endocrinology
|
December 6, 2023
Type 1 diabetes mellitus: a brave new world
Pieter-Jan Martens, Chantal Mathieu
Nature Reviews. Endocrinology
|
August 18, 2021
One hundred years of insulin therapy
Chantal Mathieu, Pieter-Jan Martens, Roman Vangoitsenhoven
The Journal of Endocrinology
|
March 17, 2021
100 YEARS OF INSULIN: Arresting or curing type 1 diabetes: an elusive goal, but closing the gap
Pieter-Jan Martens, Conny Gysemans, Chantal Mathieu
Nutrients
|
May 2, 2020
Vitamin D's Effect on Immune Function
Pieter-Jan Martens, Conny Gysemans, Annemieke Verstuyf, et al.
Annals of Internal Medicine
|
March 24, 2020
Graves Disease With Thyroid-Stimulating Hormone Receptor-Blocking Autoantibodies During Pregnancy
Brigitte Decallonne, Pieter-Jan Martens, Annick Van den Bruel, et al.
Frontiers in Endocrinology
|
November 29, 2023
Footprint of pancreas infiltrating and circulating immune cells throughout type 1 diabetes development
Ylke Bruggeman, Pieter-Jan Martens, Gabriele Sassi, et al.
Frontiers in Endocrinology
|
November 7, 2022
Preventing type 1 diabetes in late-stage pre-diabetic NOD mice with insulin: A central role for alum as adjuvant
Pieter-Jan Martens, Darcy Ellis, Ylke Bruggeman, et al.
Diabetologia
|
July 12, 2025
Verapamil and low-dose anti-mouse thymocyte globulin combination therapy stably reverses recent-onset type 1 diabetes in NOD mice by acting on the beta cell and immune axes
Laure Degroote, Pieter-Jan Martens, Marijke Viaene, et al.
Frontiers in Immunology
|
July 5, 2022
High Serum Vitamin D Concentrations, Induced <i>via</i> Diet, Trigger Immune and Intestinal Microbiota Alterations Leading to Type 1 Diabetes Protection in NOD Mice
Pieter-Jan Martens, Javier Centelles-Lodeiro, Darcy Ellis, et al.
Frontiers in Endocrinology
|
June 1, 2026
Case Report: Twenty years of metreleptin therapy in congenital generalized lipodystrophy type 1: the longest reported follow-up to date
Elise Van der Borght, Bart Van der Schueren, Roman Vangoitsenhoven, et al.
Page
of 2